Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (52)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Huizinga, T. W. J.
Right arrow Articles by Verweij, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huizinga, T. W. J.
Right arrow Articles by Verweij, C. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 1180-1188
© 2000 British Society for Rheumatology

Are differences in interleukin 10 production associated with joint damage?

T. W. J. Huizinga, V. Keijsers, G. Yanni1, M. Hall1, W. Ramage1, J. Lanchbury1, C. Pitzalis1, W. K. Drossaers-Bakker, R. G. J. Westendorp2, F. C. Breedveld, G. Panayi1 and C. L. Verweij

Department of Rheumatology and
2 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands and
1 Department of Rheumatology, GKT School of Medicine, Guy's Hospital Campus, King's College, London SE1 9RT, UK

Objective. Constitutive differences between individuals in cytokine production may determine the variation in the course of inflammatory arthritis.

Methods. The association between interleukin 10 (IL-10) production and joint destruction was studied by comparing IL-10 mRNA content in synovial biopsies from seven patients with destructive joint disease and six patients with non-destructive joint disease. The IL-10 mRNA content was 0.4 ± 0.6 arbitrary units in erosive joints compared with 2.3 ± 1.2 arbitrary units in non-erosive joints (P < 0.03, Mann–Whitney U-test). As this difference suggested that IL-10 production was associated with joint destruction, we tested whether the IL-10 locus determined the extent of joint damage.

Results. Innate differences in IL-10 production are locus-dependent. In line with these data, we showed that innate differences in IL-10 protein production were also present as differences in IL-10 mRNA levels. We tested if polymorphisms in the promoter of IL-10 were associated with the extent of joint damage.

Discussion. In a cohort study of female rheumatoid arthritis patients followed for 12 yr, the extent of joint destruction differed significantly between patients with different IL-10 genotypes. In patients with the -1082AA genotype who were studied prospectively, the mean increase in radiographic damage score (modified Sharp score of X-rays of hands and feet) during the first 6 yr was 9 ± 9 per yr vs 19 ± 16 per yr for patients with the genotype -1082GG (P < 0.02). In line with these data, cultures of endotoxin-stimulated whole blood from 158 donors showed that the presence of the allele associated with less joint destruction correlated with slightly higher IL-10 production.

Conclusions. Both the immunogenetic and the synovial biopsies suggest that a variation in IL-10 production is associated with joint destruction.

KEY WORDS: Interleukin 10, Joint damage, Genotypes.

Correspondence to: T. W. J. Huizinga, Leiden University Medical Center, Department of Rheumatology, C4-R, P. O.. Box, 9600, 2300 RC Leiden, The Netherlands.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
R Dieguez-Gonzalez, S Akar, M Calaza, E Perez-Pampin, J Costas, M Torres, J L Vicario, M L Velloso, F Navarro, J Narvaez, et al.
Genetic variation in the nuclear factor {kappa}B pathway in relation to susceptibility to rheumatoid arthritis
Ann Rheum Dis, April 1, 2009; 68(4): 579 - 583.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Crilly, J. Hamilton, C. J. Clark, A. Jardine, and R. Madhok
Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis
Rheumatology, November 1, 2003; 42(11): 1295 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
N. Pipitone, G. H. Kingsley, A. Manzo, D. L. Scott, and C. Pitzalis
Current concepts and new developments in the treatment of psoriatic arthritis
Rheumatology, October 1, 2003; 42(10): 1138 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. Asadullah, W. Sterry, and H. D. Volk
Interleukin-10 Therapy--Review of a New Approach
Pharmacol. Rev., June 1, 2003; 55(2): 241 - 269.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
D Lio, L Scola, A Crivello, G Colonna-Romano, G Candore, M Bonafe, L Cavallone, F Marchegiani, F Olivieri, C Franceschi, et al.
Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-{alpha} -308 promoter SNP
J. Med. Genet., April 1, 2003; 40(4): 296 - 299.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. MacKay, A. Milicic, D. Lee, M. Tikly, S. Laval, J. Shatford, and P. Wordsworth
Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations
Rheumatology, January 1, 2003; 42(1): 149 - 153.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
R. Gerli, C. Lunardi, and C. Pitzalis
Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis
Rheumatology, December 1, 2002; 41(12): 1341 - 1345.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. W. Gibson, J. C. Edberg, J. Wu, R. G. J. Westendorp, T. W. J. Huizinga, and R. P. Kimberly
Novel Single Nucleotide Polymorphisms in the Distal IL-10 Promoter Affect IL-10 Production and Enhance the Risk of Systemic Lupus Erythematosus
J. Immunol., March 15, 2001; 166(6): 3915 - 3922.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.